Gaudium IVF and Women Health Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Gaudium IVF and Women Health Ltd · Outcome · 13 Nov 2026, 2:01 am
Gaudium IVF and Women Health Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 3,741 (+17.9% YoY | +93.1% QoQ) ■ EBITDA: 1,347 (-2.1% YoY | +455.6% QoQ) ■ EBITDA Margin (%): 36.0 (-737 bps YoY | +2349 bps QoQ) ■ PAT: 941 (+0.4% YoY | +430.0% QoQ) ■ EPS (INR): 1.29 (-15.7% YoY | +416.0% QoQ)
Original exchange filing (PDF)
More announcements from Gaudium IVF and Women Health Ltd
- Gaudium IVF and Women Health Limited has informed the Exchange about audio recording of Earnings Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half .... · 17 Nov 2026
- Investor Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2026 · 15 Nov 2026
- Rectification of inadvertent typographical error in the unaudited consolidated financial results for the quarter and half year ended September 30,2026 · 13 Nov 2026
- Monitoring Agency Report for quarter ended September 30, 2026 · 13 Nov 2026
- Gaudium IVF and Women Health Limited has informed the Exchange regarding revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information pursuant to Regulation 8(2) of SEBI (PIT) Regulations, 2015. · 13 Nov 2026
- Revised Code of Practices and Procedures for fair Disclosure of Unpubulished Price Sensitive Information Pursuant to Regulation 8(2) of SEBI (PIT) Regulations, 2015. · 13 Nov 2026
- Gaudium IVF and Women Health Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 13 Nov 2026
- Statement of Deviation(s) or variation(s) Under Regulation 32 for the quarter ended September 30, 2026. · 13 Nov 2026
